develop
safe
effici
avian
influenza
vaccin
human
anim
use
essenti
prevent
virul
outbreak
pandem
worldwid
studi
construct
recombin
gene
fusion
lactococcu
lacti
strain
express
display
avian
influenza
viru
antigen
surfac
vector
administ
oral
deliveri
without
addit
cholera
toxin
subunit
b
ctb
result
immun
respons
analyz
mice
eventu
challeng
lethal
dose
virus
signific
titer
hemagglutinin
ha
specif
serum
igg
fecal
iga
detect
group
also
receiv
ctb
cellular
immun
also
shown
cell
prolifer
gamma
interferon
enzymelink
immunospot
elispot
assay
importantli
mice
receiv
l
lacti
strain
combin
ctb
complet
protect
lethal
challeng
viru
find
support
develop
l
lactisbas
avian
influenza
viru
vaccin
human
anim
use
spread
highli
pathogen
avian
influenza
hpai
viru
remain
major
global
concern
addit
mani
outbreak
report
variou
bird
popul
yearli
world
human
case
infect
also
report
world
health
organ
http
wwwwhointcsrdiseas
html
sinc
virus
go
constant
genet
chang
one
day
may
acquir
abil
transmit
among
human
lead
human
pandem
threat
therefor
promin
import
implement
safe
effect
vaccin
strategi
help
contain
viral
spread
anim
deter
develop
major
threat
anim
human
health
previou
studi
variou
construct
vaccin
develop
test
wide
accept
strategi
administ
heatinactiv
virus
produc
embryon
egg
howev
mani
report
approach
requir
larg
dose
dead
viru
elicit
protect
immun
respons
seroconvers
rate
suboptimum
addit
ineffici
manufactur
procedur
inconveni
vaccin
procedur
intramuscular
inject
prevent
wider
use
vaccin
construct
therefor
peopl
constant
search
effici
effect
vaccin
construct
mani
studi
explor
differ
vaccin
focus
viru
surfac
hemagglutinin
ha
antigen
studi
shown
vaccin
construct
contain
recombin
ha
protein
plasmid
dna
encod
ha
nonrepl
adenovirusvector
influenza
vaccin
could
induc
protect
immun
respons
mice
howev
would
requir
intramuscular
inject
even
electropor
could
still
limit
applic
especi
larg
popul
anim
recent
use
lactococcu
lacti
present
viru
antigen
attempt
l
lacti
gramposit
lactic
acid
bacterium
wide
use
product
preserv
ferment
milk
product
gener
regard
safe
gra
order
improv
immun
effici
recombin
l
lacti
variou
approach
explor
oral
dosag
rout
administr
adjuv
antigen
locat
surfac
cytoplasm
extracellular
among
method
mucos
immun
rout
intranas
oral
combin
nontox
b
subunit
cholera
toxin
ctb
strong
mucos
adjuv
regard
best
way
improv
immun
effici
heterolog
protein
display
cell
surfac
anchor
domain
show
better
immun
outcom
protein
express
intracellularli
use
pgsa
bacillu
subtili
ctermin
anchor
protein
verifi
lee
et
al
studi
develop
construct
express
antigen
gene
viru
base
lactococcu
lacti
strain
l
lacti
engin
express
variou
protein
includ
bacteri
viral
antigen
induc
antigenspecif
mucos
well
system
immun
respons
importantli
safe
administ
oral
show
immun
protect
lethal
challeng
viru
could
achiev
optim
l
lactisbas
construct
mucos
formul
plasmid
construct
transform
fragment
contain
pgsa
gene
amplifi
chromosom
dna
bacillu
subtili
pcr
use
primer
pgsaf
pgsar
spei
site
underlin
gene
fragment
encod
protein
contain
sequenc
encod
globular
domain
ha
genbank
access
amplifi
use
follow
primer
pair
hindiii
site
underlin
pgsa
dna
fragment
dna
fragment
fuse
bridg
pcr
use
primer
pgsaf
contain
spei
hindiii
site
respect
gener
surfac
display
plasmid
result
dna
fragment
digest
speihindiii
insert
similarli
digest
transcript
control
nisa
promot
gener
fig
result
plasmid
transform
l
lacti
electropor
creat
l
lacti
strain
neg
control
l
lacti
transform
pgsa
gene
gener
l
lacti
pgsa
strain
nisincontrol
antigen
express
recombin
l
lacti
cell
cultur
broth
medium
gml
chloramphenicol
contain
wtvol
glucos
overnight
without
agit
overnight
cultur
recombin
l
lacti
cell
dilut
fresh
medium
contain
gml
chloramphenicol
optic
densiti
nm
od
reach
nisin
ad
final
concentr
ngml
growth
continu
h
western
blot
analysi
confirm
gene
express
l
lacti
pgsa
cell
harvest
induct
centrifug
g
min
cell
pellet
wash
twice
mm
trishcl
ph
cell
lysat
supernat
analyz
western
blot
briefli
fraction
mix
equal
volum
sodium
dodecyl
sulfat
sd
buffer
mm
trishcl
ph
sd
glycerol
bromophenol
blue
boil
min
cell
lysat
electrophores
acrylamid
gel
transfer
nitrocellulos
membran
protein
detect
use
polyclon
mous
antiha
antibodi
follow
affinitypurifi
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
membran
radiograph
xfilm
use
ecl
western
blot
detect
system
pierc
flow
cytometr
analysi
immunofluoresc
microscopi
investig
whether
protein
express
surfac
l
lacti
l
lacti
pgsa
cell
centrifug
g
min
wash
three
time
steril
phosphatebuff
salin
pb
bacteria
incub
polyclon
mous
antiha
antibodi
overnight
follow
biotinyl
goat
antimous
igg
phycoerythrin
pe
conjug
streptavidin
stain
cell
analyz
flow
cytometri
bd
facscalib
immunofluoresc
stain
l
lacti
pgsa
cell
harvest
induct
incub
polyclon
mous
antiha
antibodi
min
follow
fluorescein
isothiocyan
fitc
conjug
antimous
igg
l
lacti
pgsa
strain
use
neg
control
immunofluores
analysi
examin
use
fluoresc
microscop
olympu
japan
oral
immun
mice
sixweekold
balbc
femal
mice
purchas
slc
inc
shanghai
china
hous
anim
center
school
pharmaci
shanghai
jiao
tong
univers
mice
kept
standard
specificpathogenfre
spf
condit
provid
free
access
food
water
experi
overnight
fast
group
mice
receiv
use
oral
zond
needl
l
cfu
l
lacti
pgsa
strain
plu
mg
ctb
purchas
sigma
recombin
protein
comparison
group
administ
dose
l
lacti
pgsa
strain
immun
perform
daili
via
intragastr
lavag
day
elisa
sampl
sera
collect
retroorbit
punctur
fece
collect
day
final
immun
sera
store
use
fecal
pellet
mg
suspend
ml
steril
pb
centrifug
g
min
supernat
collect
test
iga
enzymelink
immunosorb
assay
elisa
igg
detect
perform
avidinbiotin
system
ab
elisa
iga
antibodi
assay
indirect
elisa
briefli
micropl
coat
recombin
influenza
viru
ha
protein
overnight
well
block
bovin
serum
albumin
bsa
incub
h
room
temperatur
twofold
serial
dilut
serum
fecal
suspens
l
ad
h
bound
antibodi
detect
use
biotinconjug
goat
antimous
igg
alkalin
phosphataseconjug
streptavidin
r
system
hrpconjug
goat
antimous
iga
sigma
mean
antibodi
titer
express
reciproc
serial
serum
dilut
reach
cutoff
valu
plu
standard
deviat
sd
elispot
assay
gamma
interferon
produc
cell
quantifi
week
final
immun
use
elispot
kit
r
system
accord
manufactur
instruct
briefli
mous
micropl
ad
lwell
splenocyt
gml
haspecif
peptid
isvgtstlnqrlvp
use
stimuli
h
humidifi
co
incub
control
well
contain
unstimul
cell
incub
well
wash
plate
incub
sequenti
biotinyl
antimous
antibodi
alkalin
phosphataseconjug
streptavidin
substrat
solut
reveal
spot
number
spot
count
dissect
microscop
assay
perform
triplic
statist
analysi
statist
analys
perform
use
student
test
data
p
valu
consid
statist
signific
pgsa
dna
fragment
fuse
bridg
pcr
system
gener
gene
digest
gene
transcript
fuse
yield
fig
result
plasmid
transform
l
lacti
strain
purifi
plasmid
recombin
l
lacti
pgsa
strain
detect
agaros
gel
electrophoresi
fig
shown
lane
fragment
bp
success
digest
western
blot
analysi
cell
lysat
supernat
show
locat
surfac
l
lacti
strain
intracellularli
fig
band
kda
like
repres
protein
kda
pgsa
surfac
display
motif
kda
determin
whether
protein
express
surfac
l
lacti
via
cell
wall
anchor
fluorescenceactiv
cell
sorter
fac
analysi
reveal
signific
increas
fluoresc
intens
obtain
l
lacti
strain
fig
immunofluoresc
show
cell
harbor
l
lacti
strain
immunostain
posit
control
cell
harbor
l
lacti
pgsa
strain
fig
data
indic
construct
recombin
l
lacti
strain
could
make
protein
effect
display
surfac
cell
wall
immun
respons
induc
oral
vaccin
l
lacti
ctb
mice
total
l
cfu
l
lacti
pgsa
strain
pgsa
ctb
without
ctb
oral
administ
balbc
mice
spf
grade
effect
vaccin
product
haspecif
serum
igg
fecal
iga
examin
day
final
immun
shown
fig
igg
antibodi
titer
obtain
show
signific
increas
compar
group
fecal
iga
also
examin
significantli
produc
immun
l
lacti
ctb
strain
fig
data
demonstr
administr
mice
l
lacti
ctb
strain
result
signific
enhanc
haspecif
igg
mucos
iga
compar
control
administ
pb
l
lacti
pgsa
pgsa
ctb
strain
l
lacti
ctb
strain
immun
stimul
haspecif
cellular
immun
respons
determin
whether
l
lacti
ctb
strain
could
induc
cellular
immun
lymphoprolifer
elispot
assay
perform
splenocyt
stimul
gml
recombin
ha
protein
prolifer
level
reflect
absorb
nm
spectrophotomet
compar
result
mice
immun
pb
l
lacti
pgsa
pgsa
ctb
strain
signific
enhanc
observ
elispot
assay
number
haspecif
cell
l
lacti
ctb
treat
mice
significantli
greater
group
p
fig
result
suggest
oral
administr
l
lacti
ctb
strain
could
effect
induc
haspecif
cell
mediat
respons
cellmedi
immun
cmi
protect
lethal
viru
challeng
test
whether
vaccin
mice
could
stand
viru
challeng
mice
mice
group
infect
intranas
drip
lethal
dose
l
ld
viru
infect
surviv
rate
observ
day
result
percent
surviv
indic
mice
immun
l
lacti
ctb
strain
obtain
protect
contrast
group
kill
within
day
fig
data
demonstr
l
lacti
ctb
strain
effect
vaccin
provid
complet
protect
viru
challeng
studi
demonstr
oral
administr
recombin
l
lacti
strain
surfacedisplay
antigen
combin
mucos
adjuv
ctb
could
induc
suffici
haspecif
mucos
system
immun
respons
protect
viru
lethal
challeng
balbc
mice
mucos
surfac
first
line
defens
effect
elimin
mani
pathogen
prevent
highli
pathogen
avian
influenza
viru
infect
consid
favor
develop
suffici
mucos
immun
first
line
defens
vaccin
mucos
rout
need
gener
mucos
immun
respons
prabakaran
et
al
construct
recombin
baculoviru
surfacedisplay
ha
protein
show
efficaci
inactiv
influenza
vaccin
intranas
administr
show
vector
combin
ctb
adjuv
could
achiev
protect
homogen
viru
challeng
mice
saluja
et
al
show
influenza
viru
subunit
vaccin
formul
gramposit
enhanc
matrix
gem
particl
adjuv
could
produc
effect
protect
conclud
gem
l
lacti
safe
adjuv
howev
intranas
rout
administr
limit
dose
volum
mucos
exposur
deliveri
effici
may
highli
variabl
oral
administr
rout
consid
much
conveni
comparison
antigen
also
access
larger
mucos
area
prolong
durat
howev
protein
deliv
oral
easili
degrad
low
immunogen
essenti
develop
specif
vaccin
deliveri
system
adjuv
facilit
antigen
interact
host
immun
system
l
lacti
nonpathogen
noninvas
noncommens
foodgrad
bacterium
consid
ideal
mucos
deliveri
vector
l
lactisderiv
vector
wide
use
superior
safeti
profil
compar
bacteri
base
live
vector
mycobacterium
bovi
bacillu
bcg
listeria
monocytogen
salmonella
shigella
howev
may
less
immunogen
virul
vector
order
improv
previous
report
develop
recombin
l
lacti
strain
oral
immun
enter
minicapsul
use
nisincontrol
express
nice
system
construct
l
lacti
vector
express
secret
ha
antigen
studi
modifi
express
system
display
antigen
protein
surfac
l
lacti
pgsa
anchor
motif
believ
modif
improv
antigen
stabil
oral
time
facilit
antigen
present
bacteria
cell
wall
anchor
protein
found
resist
proteolysi
easili
taken
epitheli
cell
small
intestin
furthermor
oral
administ
vaccin
also
consid
essenti
incorpor
special
adjuv
boost
interact
nucos
immun
system
variou
synthet
vector
microspher
liposom
nanoparticl
immunostimul
complex
iscom
test
show
improv
immun
respons
efficaci
optim
certain
bacteri
toxin
cholera
toxin
ct
escherichia
coli
heatlabil
enterotoxin
lt
consid
immunogen
although
toxin
toxic
gener
previou
studi
shown
b
subunit
may
benign
function
unit
involv
recognit
bind
gangliosid
cell
receptor
recombin
ctb
lt
subunit
b
ltb
use
success
sever
vaccin
studi
adjuv
oral
administr
stimul
upregul
express
antigenpres
cell
apc
promot
immun
respons
studi
confirm
immunestimul
effect
ctb
ctb
protein
simpli
mix
haexpress
l
lacti
vector
administ
oral
result
igg
iga
respons
higher
cellmedi
respons
also
improv
compar
data
obtain
l
lacti
vector
alon
fig
fig
think
immuneadjuv
effect
ctb
studi
critic
gener
protect
immun
viru
challeng
experi
heterolog
crossprotect
variou
diverg
strain
ongo
summari
construct
recombin
l
lacti
strain
antigen
display
surfac
cell
wall
oral
administr
mucos
vaccin
combin
ctbinduc
strong
haspecif
humor
mucos
immun
respons
significantli
stand
challeng
lethal
dose
viru
find
indic
recombin
l
lacti
strain
use
safe
effect
inexpens
mucos
vaccin
deliveri
vector
